| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 2,152,000 | 2,250,000 | 1,921,000 | 2,177,000 | | Cost of Revenue | 1,138,000 | 1,201,000 | 998,000 | 1,165,000 | | | Gross Profit | 1,014,000 | 1,049,000 | 923,000 | 1,012,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 371,000 | 393,000 | 365,000 | 352,000 | | Non Recurring |
-
|
-
| 453,000 | 144,000 | | Others | 7,000 | 7,000 | 8,000 | 6,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 636,000 | 649,000 | 97,000 | 510,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,000 | 17,000 | (14,000) | (25,000) | | Earnings Before Interest And Taxes | 639,000 | 666,000 | 83,000 | 485,000 | | Interest Expense | 60,000 | 64,000 | 66,000 | 67,000 | | Income Before Tax | 579,000 | 602,000 | 17,000 | 418,000 | | Income Tax Expense | 217,000 | 225,000 | 9,000 | 160,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 362,000 | 377,000 | 8,000 | 258,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 362,000 | 377,000 | 8,000 | 258,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $362,000 | $377,000 | $8,000 | $258,000 |
|
1.29% Nasdaq 0.00%
Income Statement
